HER2 Negative Breast Cancer Overview

Save information for later
Sign Up

Learn About HER2 Negative Breast Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top HER2 Negative Breast Cancer Local Doctors?
Christoph Thomssen
Elite in HER2 Negative Breast Cancer
Elite in HER2 Negative Breast Cancer
Ernst Grube Str. 40, 
Halle, NI, DE 

Christoph Thomssen practices in Halle, Germany. Mr. Thomssen is rated as an Elite expert by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are HER2 Negative Breast Cancer, Breast Cancer, BRCA Positive Breast Cancer, Mastectomy, and Hormone Replacement Therapy (HRT).

Patrick Neven
Elite in HER2 Negative Breast Cancer
Elite in HER2 Negative Breast Cancer

UZ Leuven, Campus Gasthuisberg

Leuven, VLG, BE 

Patrick Neven practices in Leuven, Belgium. Mr. Neven is rated as an Elite expert by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Menopause, Mastectomy, and Hormone Replacement Therapy (HRT).

 
 
 
 
Learn about our expert tiers
Learn More
Kevin M. Kalinsky
Elite in HER2 Negative Breast Cancer
Elite in HER2 Negative Breast Cancer

Emory Winship Cancer Institute

1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
Languages Spoken:
English
Offers Telehealth

Kevin Kalinsky is an Oncologist in Atlanta, Georgia. Dr. Kalinsky is rated as an Elite provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Inflammatory Breast Cancer, and Triple-Negative Breast Cancer.

What are the latest HER2 Negative Breast Cancer Clinical Trials?
A Phase 2 Trial of (Z)-Endoxifen + Goserelin as Neoadjuvant Treatment for Premenopausal Women With ER+, HER2-, Breast Cancer

Summary: This open-label research study is studying (Z)-endoxifen as a possible treatment for pre-menopausal women with ER+/HER2- breast cancer. (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or SERM, which help block estrogen from attaching to cancer cells. This study has two parts: a pharmacokinetic part and a treatment part. The PK part (how the body processes th...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Clinical Trial to Evaluate the Efficacy and Safety of SI-B003 Monotherapy or BL-B01D1+SI-B003 Combination Therapy (BL-B01D1+SI-B003) in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer

Summary: This phase II study is a clinical study to explore the efficacy and safety of SI-B003 monotherapy and BL-B01D1+SI-B003 combination therapy in patients with unresectable locally advanced or recurrent metastatic HER-2 negative breast cancer.